|Articles|March 17, 2010
Supplements and Featured Publications
- Implications of Early Treatment for Parkinson’s Disease [CME/CPE]
- Volume 16
- Issue 4
Posttest: Implications of Early Treatment for Parkinson's Disease
Advertisement
Instructions
After reading “Implications of Early Treatment for Parkinson’s Disease,” complete the program evaluation and select the 1 best answer to each of the following questions.
A statement of continuing education hours will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher.
Articles in this issue
about 16 years ago
Participating Facultyabout 16 years ago
Early Pharmacologic Treatment in Parkinson's DiseaseAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
3
Bridging Science and Reality in Diabetes Care
4
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
5